Details for 2015730858

Up to date per 02.04.2026

Actions

Title / Product Name

VERWENDUNG VON SERELAXIN ZUR REDUZIERUNG VON GDF-15

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015730858

EP Publication Number

3154559

E-Number

1425498

Language

PCT Number

IB15054399

Publication Date

19.04.2017 A

01.09.2021 B1

Registration Date

01.09.2021

AT Publication Date

15.09.2021

Application Date

10.06.2015

Registration Number

Priorities

13.06.2014

201462011744 P

IPC

A61K 38/00 20060101AFI20201028BHEP

Maximum Duration of Protection

10.06.2035

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

PRESCOTT, Margaret Forneyc/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

ZHANG, Yimingc/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

DAHLKE, Marionc/o Novartis Pharma AG Fabrikstrasse 2 Novartis Campus CH-4056 BaselCH

SEVERIN, ThomasNovartis Pharma AG Forum 1 Novartis Campus 4056 BaselCH